12:00 AM
 | 
Aug 27, 2012
 |  BC Week In Review  |  Company News  |  Deals

Synergy Pharmaceuticals, Bristol-Myers deal

Synergy acquired FV-100 from Bristol-Myers Squibb six months after the pharma gained the shingles product through its $2.5 billion takeover...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >